Zydus Lifesciences Limited (ZYDUSLIFE.BO)
INR 859.55
(2.64%)
INR 859.55
(2.64%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 38.59 Billion INR | 96.88% |
| 2023 | 19.6 Billion INR | -56.31% |
| 2022 | 44.87 Billion INR | 110.32% |
| 2021 | 21.33 Billion INR | 81.34% |
| 2020 | 11.76 Billion INR | -36.36% |
| 2019 | 18.48 Billion INR | 4.11% |
| 2018 | 17.75 Billion INR | 19.37% |
| 2017 | 14.87 Billion INR | -23.07% |
| 2016 | 19.33 Billion INR | 68.38% |
| 2015 | 11.48 Billion INR | 42.92% |
| 2014 | 8.03 Billion INR | 22.97% |
| 2013 | 6.53 Billion INR | 0.14% |
| 2012 | 6.52 Billion INR | -8.21% |
| 2011 | 7.11 Billion INR | 40.76% |
| 2010 | 5.05 Billion INR | 66.64% |
| 2009 | 3.03 Billion INR | 17.66% |
| 2008 | 2.57 Billion INR | 10.18% |
| 2007 | 2.33 Billion INR | 53.41% |
| 2006 | 1.52 Billion INR | 27.11% |
| 2005 | 1.19 Billion INR | -9.92% |
| 2004 | 1.33 Billion INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | 11.82 Billion INR | 49.73% |
| 2024 Q2 | 8 Billion INR | -26.33% |
| 2024 FY | 38.59 Billion INR | 96.88% |
| 2024 Q3 | 7.89 Billion INR | -1.39% |
| 2024 Q1 | 10.86 Billion INR | 266.45% |
| 2023 Q2 | 5.22 Billion INR | 0.81% |
| 2023 FY | 19.6 Billion INR | -56.31% |
| 2023 Q4 | 2.96 Billion INR | -52.38% |
| 2023 Q3 | 6.22 Billion INR | 19.22% |
| 2023 Q1 | 5.18 Billion INR | 30.42% |
| 2022 Q1 | 5.87 Billion INR | -13.52% |
| 2022 FY | 44.87 Billion INR | 110.32% |
| 2022 Q4 | 3.97 Billion INR | -20.58% |
| 2022 Q3 | 5 Billion INR | -83.33% |
| 2022 Q2 | 30.02 Billion INR | 411.29% |
| 2021 Q2 | 5.11 Billion INR | 12.73% |
| 2021 FY | 21.33 Billion INR | 81.34% |
| 2021 Q1 | 4.54 Billion INR | 15.85% |
| 2021 Q4 | 6.79 Billion INR | 28.79% |
| 2021 Q3 | 5.27 Billion INR | 3.01% |
| 2020 Q2 | 1.07 Billion INR | -64.69% |
| 2020 Q1 | 3.03 Billion INR | -34.01% |
| 2020 FY | 11.76 Billion INR | -36.36% |
| 2020 Q4 | 3.91 Billion INR | 4.81% |
| 2020 Q3 | 3.73 Billion INR | 248.79% |
| 2019 Q2 | 4.17 Billion INR | -9.34% |
| 2019 Q4 | 4.6 Billion INR | -9.91% |
| 2019 Q1 | 4.6 Billion INR | -24.1% |
| 2019 Q3 | 5.1 Billion INR | 22.32% |
| 2019 FY | 18.48 Billion INR | 4.11% |
| 2018 Q1 | 1.38 Billion INR | -64.23% |
| 2018 Q3 | 5.43 Billion INR | 7.95% |
| 2018 Q4 | 6.06 Billion INR | 11.67% |
| 2018 FY | 17.75 Billion INR | 19.37% |
| 2018 Q2 | 5.03 Billion INR | 263.66% |
| 2017 Q1 | 3.8 Billion INR | -31.74% |
| 2017 FY | 14.87 Billion INR | -23.07% |
| 2017 Q4 | 3.86 Billion INR | 19.45% |
| 2017 Q3 | 3.23 Billion INR | -14.74% |
| 2017 Q2 | 3.79 Billion INR | -0.08% |
| 2016 Q2 | 4.57 Billion INR | 4.03% |
| 2016 FY | 19.33 Billion INR | 68.38% |
| 2016 Q3 | 4.37 Billion INR | -4.37% |
| 2016 Q1 | 4.39 Billion INR | 26.19% |
| 2016 Q4 | 5.57 Billion INR | 27.4% |
| 2015 Q2 | 2.78 Billion INR | 15.77% |
| 2015 Q3 | 2.81 Billion INR | 1.37% |
| 2015 Q4 | 3.48 Billion INR | 23.55% |
| 2015 Q1 | 2.4 Billion INR | 0.42% |
| 2015 FY | 11.48 Billion INR | 42.92% |
| 2014 Q3 | 1.85 Billion INR | 1.42% |
| 2014 FY | 8.03 Billion INR | 22.97% |
| 2014 Q4 | 2.39 Billion INR | 28.62% |
| 2014 Q2 | 1.83 Billion INR | -5.99% |
| 2014 Q1 | 1.95 Billion INR | -25.17% |
| 2013 Q1 | 1.94 Billion INR | 13.99% |
| 2013 Q2 | 946.4 Million INR | -51.41% |
| 2013 Q3 | 1.02 Billion INR | 8.24% |
| 2013 FY | 6.53 Billion INR | 0.14% |
| 2013 Q4 | 2.6 Billion INR | 154.45% |
| 2012 Q2 | 1.17 Billion INR | 0.0% |
| 2012 Q3 | 1.49 Billion INR | 26.75% |
| 2012 Q4 | 1.7 Billion INR | 14.53% |
| 2012 FY | 6.52 Billion INR | -8.21% |
| 2011 FY | 7.11 Billion INR | 40.76% |
| 2010 FY | 5.05 Billion INR | 66.64% |
| 2009 FY | 3.03 Billion INR | 17.66% |
| 2008 FY | 2.57 Billion INR | 10.18% |
| 2007 FY | 2.33 Billion INR | 53.41% |
| 2006 FY | 1.52 Billion INR | 27.11% |
| 2005 FY | 1.19 Billion INR | -9.92% |
| 2004 FY | 1.33 Billion INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | -526.725% |
| Aurobindo Pharma Limited | 31.72 Billion INR | -21.637% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | -719.622% |
| Granules India Limited | 4.05 Billion INR | -852.234% |
| Indoco Remedies Limited | 984.6 Million INR | -3819.862% |
| Achyut Healthcare Limited | 5.73 Million INR | -673225.192% |
| Ajanta Pharma Limited | 8.16 Billion INR | -372.879% |
| Alkem Laboratories Limited | 17.95 Billion INR | -114.922% |
| Alpa Laboratories Limited | 167.76 Million INR | -22905.394% |
| Brooks Laboratories Limited | -195.91 Million INR | 19799.468% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | -2289.635% |
| Bajaj HealthCare Limited | -837.93 Million INR | 4705.988% |
| Bliss GVS Pharma Limited | 754.54 Million INR | -5015.03% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 30.689% |
| Eris Lifesciences Limited | 3.91 Billion INR | -884.609% |
| FDC Limited | 3.05 Billion INR | -1164.484% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 357.014% |
| Gufic Biosciences Limited | 861.35 Million INR | -4380.726% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | -816.829% |
| Ipca Laboratories Limited | 5.47 Billion INR | -605.125% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -17081.587% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 19663.168% |
| Lasa Supergenerics Limited | -217.3 Million INR | 17860.669% |
| Laurus Labs Limited | 1.6 Billion INR | -2303.924% |
| Lupin Limited | 19.14 Billion INR | -101.595% |
| Mankind Pharma Limited | 19.12 Billion INR | -101.762% |
| Medicamen Biotech Limited | 109.31 Million INR | -35207.84% |
| Medico Remedies Limited | 82.9 Million INR | -46451.038% |
| Megasoft Limited | -127.46 Million INR | 30378.663% |
| NATCO Pharma Limited | 13.88 Billion INR | -178.002% |
| Piramal Pharma Limited | 178.2 Million INR | -21558.249% |
| RPG Life Sciences Limited | 876.6 Million INR | -4302.806% |
| Sigachi Industries Limited | 571.8 Million INR | -6649.714% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 59.698% |
| Suven Pharmaceuticals Limited | 3 Billion INR | -1185.298% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -15146.383% |
| Unichem Laboratories Limited | -704.74 Million INR | 5576.464% |
| Wanbury Limited | 559.56 Million INR | -6797.347% |
| Windlas Biotech Limited | 581.87 Million INR | -6532.925% |
| ZIM Laboratories Limited | 172.46 Million INR | -22278.583% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 1096.736% |
| Divi's Laboratories Limited | 16 Billion INR | -141.219% |
| Hester Biosciences Limited | 188.89 Million INR | -20332.527% |
| Procter & Gamble Health Limited | 2 Billion INR | -1820.34% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -8481.892% |
| Bal Pharma Limited | 73.92 Million INR | -52110.438% |
| Strides Pharma Science Limited | -706.14 Million INR | 5565.63% |
| Venus Remedies Limited | 284.9 Million INR | -13446.478% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | -1679.375% |
| Nectar Lifesciences Limited | 49.95 Million INR | -77167.267% |
| Shilpa Medicare Limited | 318.74 Million INR | -12008.539% |
| Aarti Drugs Limited | 1.71 Billion INR | -2151.511% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | -2771.011% |
| Suven Life Sciences Limited | -1.05 Billion INR | 3773.045% |
| Ind-Swift Limited | 142.31 Million INR | -27019.799% |
| Valiant Laboratories Limited | 3.19 Million INR | -1207503.254% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | -598.39% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 780.22% |
| Themis Medicare Limited | 435.23 Million INR | -8767.562% |
| Hikal Limited | 696.02 Million INR | -5445.099% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | -133.008% |
| Sequent Scientific Limited | -358.69 Million INR | 10859.988% |
| Novartis India Limited | 851.9 Million INR | -4430.461% |
| Wockhardt Limited | -4.63 Billion INR | 933.585% |
| Jubilant Pharmova Limited | 771 Million INR | -4905.837% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -544104.738% |
| Neuland Laboratories Limited | 3 Billion INR | -1186.162% |
| Morepen Laboratories Limited | 961.59 Million INR | -3913.627% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -26332.397% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 42644.396% |